Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) lost 0.45% by the end of recent close at $ 139.74. The percentage change in the price over the last fifty two weeks remained -14.35%. The price range in those 52 weeks had a highest hit of $124.16 while lowest level in that period was $208.88. Latest closing price was -2.86% above its 50-day moving average and -14.07% below its 200-day moving average.
On April 28, 2016 Alexion Pharmaceuticals, Inc. (ALXN) announced financial results for the first quarter of 2016. Total revenues grew to $701 million, a 17 percent increase, compared to $600 million for the same period in 2015. In the first quarter, the negative impact of currency on total revenue was 5 percent or $30 million, net of hedging activities, compared to the same quarter last year. First quarter revenue growth was further negatively impacted by increased macroeconomic weakness in Latin American countries, primarily Brazil and Argentina. Non-GAAP diluted earnings per share (EPS) for the first quarter of 2016 was $1.11 per share, compared to $1.28 per share in the first quarter of 2015. On a GAAP basis, diluted EPS for the first quarter of 2016 was $0.41 per share, compared to $0.45 per share in the first quarter of 2015.
Shares of Novavax, Inc. (NASDAQ:NVAX) traded down 1.85% in last trading session to close the session at a price $ 4.41 share. With an average trading capacity of 4.41 shares, the number of shares traded in most recent session was 3,326,400 shares. Its previous 52-week high was $ -70.62 and moved down 8.09% over the same period, currently having a market cap around $ 1.17B. Shares have added -35.05% over the trailing 6 months. The stock presently trades -14.63% below its SMA 50 and -40.00% below its SMA 200.
On May 12, 2016 Novavax, Inc. (NVAX) announced it received the Tech Council of Maryland’s (TCM) Chairman’s Award. The award was announced at the TCM Industry Award Celebration on May 11, 2016.
The Chairman’s Award is presented to a member company or individual that best exemplifies excellence in Maryland’s technology or life science industry. The Award recognizes a company that is a pillar in the community, not only through market success or job creation, but by consistently giving back, getting involved and advancing the climate for innovation.